Pharma/Biotech News - BioPharm International


Pharma/Biotech News
News from pharmaceutical and biopharmaceutical companies, including mergers, acquisitions, drug approvals, business development.

Bristol-Myers Squibb and Celgene Collaborate on Immunotherapy and Chemotherapy Combination Regimen

August 20, 2014

The companies will conduct clinical trials to evaluate a combination immune checkpoint inhibitor and a chemotherapy.

Novartis Personalized Cell Therapy Receives FDA Breakthrough Therapy Designation

July 9, 2014

FDA grants breakthrough therapy designation to Novartis chimeric antigen receptor therapy.

Merck to Acquire Idenix

June 11, 2014

Merck acquires Idenix Pharmaceuticals for $3.85 billion.

Aastrom Acquires Sanofi's Cell Therapy and Regenerative Medicine Business

June 3, 2014

Aastrom acquires Sanofi's CTRM business unit for $6.5 million.

Agenus Collaborates with Merck for Novel Checkpoint Antibody-Based Cancer Immunotherapies

April 30, 2014

Agenus and Merck work together to advance immune-oncology programs.

Bristol-Myers Squibb Acquires iPierian

April 30, 2014

BMS acquisition of iPierian advances BMS' pursuit of therapeutics for genetically defined diseases.

Sun Pharma to Acquire Ranbaxy

April 7, 2014

Sun Pharma acquisition of Ranbaxy Laboratories will create the fifth-largest specialty generics company in the world.

Baxter to Split Into Biopharmaceuticals and Medical Products Companies

March 27, 2014

Baxter announces plans to split into two independent companies by mid-2015.

Novartis calls for more research to understand and find treatments for rare disease.

March 4, 2014

Novartis calls for more research to understand and find treatments for rare disease.



Click here